Company intelligence / Profile preview

BiomCare

Dobříš, Czech Republic

Ownership: Private
Development stage: Other

Overview

BiomCare has developed, patented, and commercialized several skin microbiome-focused products in Europe, with ongoing expansion to the US. Their products support skin barrier regeneration, especially for chronically damaged, atopic, or sensitive skin by restoring microbiome balance, and have undergone practical and clinical testing with obtained safety reports for EU market entry.[2][3]

Therapeutic areas: Infectious DiseasesDermatology
Modalities: Live biotherapeutic product therapyMicrobial therapyCosmetic
Industry: Therapeutic Medical Devices

Partnerships

Laboratory and practical testing partners (unnamed)Professional companies for independent tests in cosmetics safety (unnamed)

Beyond the preview

Go deeper on BiomCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BiomCare.

Explore the full profile